Companies / Upstream Bio, Inc.
Upstream Bio, Inc.
Nasdaq: UPBCIK 2022626WALTHAM, MA
Financials · FY2025
Ownership
54.8M shares outstanding · as of Aug 4, 2026
Ownership
| Insiders | 0.32% | 175,215 |
| Institutions | 96.30% | 52,742,183 |
| Public float | 3.38% | 1,853,643 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 6
View all →| Insider | % of shares | Shares |
|---|---|---|
Sutherland Everett RandCEOChief Executive Officer · Director | 0.13% | 72,907 |
Deykin AaronChief Medical Officer | 0.06% | 32,687 |
Gray MichaelCFO and COO | 0.05% | 28,795 |
Houghton AdamChief Business Officer | 0.04% | 24,301 |
Ambrose AllisonGeneral Counsel | 0.03% | 16,525 |
Renaud Ronald C JRDirector | — | — |
Institutional holders 142
View all →| Holder | Value | % of shares |
|---|---|---|
| $204.12M | 13.73% | |
| $85.33M | 5.74% | |
| $78.26M | 5.26% | |
| $66.78M | 4.49% | |
| $64.85M | 4.36% | |
| $51.24M | 10.40% | |
| $49.04M | 3.30% | |
| $41.42M | 2.79% | |
| $36.10M | 2.43% | |
| $36.01M | 2.42% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Sutherland Everett Rand CEO | Sell | Common Stock | $19.4K | -2K -2.79% | 72,907 0.13% of shares | low |
| Mar 16, 2026 | Deykin Aaron Executive | Sell | Common Stock | $8.3K | -894 -2.66% | 32,687 0.06% of shares | low |
| Mar 16, 2026 | Gray Michael Executive | Sell | Common Stock | $7.9K | -852 -2.79% | 29,648 0.05% of shares | low |
| Mar 16, 2026 | Houghton Adam Executive | Sell | Common Stock | $6.5K | -699 -2.80% | 24,301 0.04% of shares | low |
| Jun 16, 2026 | Gray Michael Executive | Sell | Common Stock | $5.2K | -853 -2.88% | 28,795 0.05% of shares | low |
| Mar 16, 2026 | Ambrose Allison Executive | Sell | Common Stock | $4.4K | -475 -2.79% | 16,525 0.03% of shares | low |
| Jan 2, 2026 | Deykin Aaron Executive | Grant | Common Stock | $0 | +32K +2024.04% | 33,581 0.06% of shares | low |
| Jan 2, 2026 | Ambrose Allison Executive | Grant | Common Stock | $0 | +17K | 17,000 0.03% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| UPB | Common Stock | 91678A107 |